NCT02906943View on ClinicalTrials.gov

Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

RecruitingOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Breast CancerLung CancerColorectal CancerMelanomaGynecological CancerGenitourinary CancerPancreatobiliary CancerGastrointestinal CancerHead and Neck CancerRare CancerUnknown Primary Cancer
Trial Locations (7)

Unknown

ACTIVE_NOT_RECRUITING

Juravinski Cancer Centre, Hamilton

ACTIVE_NOT_RECRUITING

Kingston General Hospital, Kingston

ACTIVE_NOT_RECRUITING

London Health Sciences Centre, London

RECRUITING

The Ottawa Hospital Cancer Centre, Ottawa

ACTIVE_NOT_RECRUITING

Mount Sinai Hospital, Toronto

ACTIVE_NOT_RECRUITING

Sunnybrook Health Sciences Centre, Toronto

M5G 2M9

RECRUITING

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT02906943 - Ontario-wide Cancer TArgeted Nucleic Acid Evaluation | Biotech Hunter | Biotech Hunter